Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Goldsboro, NC MSA — September 2026
Triangle biotech boom squeezes Goldsboro's specialized talent pool.
Goldsboro's 3.7% unemployment rate and a contracting 48.4-thousand labor force leave local life sciences employers exposed as J&J's $2B Wilson County campus and Amgen's $1B Holly Springs expansion pull regulatory and quality talent toward the Triangle.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Goldsboro MSA unemployment: 3.7% — vs 3.5% NC, 4.1% national (July/Aug 2026)
- Goldsboro civilian labor force: 48.4K — Historically tight; NC labor force down ~70K YoY
- J&J Wilson County biologics investment: $2B / 420 jobs — Commuting distance from Goldsboro talent pool
- CRA advertised pay, Goldsboro metro: $90,955 — Nearly matches $90,956 national median
Key takeaways
Triangle biomanufacturing growth is draining Goldsboro's specialized talent pool.
J&J's $2B Wilson County campus and Amgen's Holly Springs expansion sit within commuting range of Goldsboro and offer premium pay for the same CMC, quality, and regulatory skill sets. Retention strategies anchored to Goldsboro-only comparables likely understate the real competitive pressure these employers face.
Entry-level manufacturing pipelines are maturing faster than specialized talent supply.
Wilson Community College's BioWork program is placing graduates into $67,000 starting roles at J&J and Fresenius Kabi, solving operator-level staffing. That pipeline does nothing for the regulatory and scientific roles where national data shows acute scarcity, meaning headcount plans should treat these as separate talent markets with different sourcing strategies.
CRA pay growth signals clinical functions are repricing nationally and locally.
Clinical Research Associate advertised pay sits at $90,955 locally, tracking almost exactly with the $90,956 national median and both trending up with significant magnitude. Local employers competing for clinical talent are effectively paying national-market rates despite Goldsboro's lower overall cost structure, a signal that clinical roles may no longer benefit from a rural pay discount.
Low local unemployment masks a shrinking labor force, not labor market strength.
Goldsboro's 3.7% unemployment rate reflects a labor force of just 48.4 thousand, consistent with the statewide pattern of contracting participation rather than job growth. Low unemployment here signals scarcity more than vitality — a distinction that matters when forecasting how long open regulatory or quality positions will stay unfilled.
Median advertised pay by role — Goldsboro, NC MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $103,601 | $123,500 | $136,449 | Moderate increase | $131,354 |
| Clinical Research Associate * | $61,514 | $90,955 | $108,600 | Significant increase | $90,956 |
| Lab Technician * | $41,439 | $49,383 | $56,836 | Significant decline | $47,402 |
| Regulatory Affairs Specialist * | $77,989 | $119,275 | $119,887 | Significant increase | $104,000 |
| Clinical Data Manager * | $101,184 | $118,202 | $121,795 | Stable | $123,031 |
| Biostatistician * | $113,295 | $142,332 | $169,605 | Significant increase | $133,322 |
| Validation Engineer * | $90,115 | $96,700 | $108,040 | Stable | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Goldsboro's labor market held historically tight through July 2026, with unemployment at 3.7% against a 48.4-thousand-person civilian labor force that leaves little slack for specialized hiring, while Seymour Johnson AFB and Wayne Memorial Hospital continue to anchor demand for credentialed talent against a backdrop of flat statewide labor force growth. Statewide, North Carolina's broader life sciences buildout — Amgen's $1B Holly Springs expansion and J&J's $2B Wilson County biologics campus, both within commuting distance of eastern NC's talent pool — is pulling experienced scientific, quality, and regulatory staff toward larger metros, intensifying competition for the smaller pool of specialized candidates remaining in Goldsboro.
What it means
Goldsboro-based life sciences employers face a structural disadvantage against Triangle-area biomanufacturing investment: candidates with CMC, quality, or regulatory credentials increasingly have higher-paying alternatives within an hour's drive, which raises the cost of retention even where local unemployment is low. Build-vs-outsource calculus shifts further toward CDMO partnerships for specialized functions when internal hiring timelines lengthen and competing offers from Holly Springs or Wilson County enter candidate negotiations. Organizations should evaluate whether critical regulatory and quality roles need geographic pay differentials benchmarked against Triangle biomanufacturing rates rather than Goldsboro's broader metro wage data.
Looking ahead
Worth watching: NC Life Sciences Organization's Q3 forum raised explicit concerns about whether the state's biomanufacturing workforce can keep pace with expansion. Watch for follow-on commentary or workforce studies that quantify the specialized-talent gap specifically, as this will shape regional compensation benchmarks over the next two quarters.
Emerging pressure point: Healthcare WARN notices statewide have affected 1,455 workers this year, the third-highest category behind manufacturing and transportation. Monitor whether any Wayne Memorial Hospital-adjacent restructuring activity surfaces, which could either release clinical talent into the Goldsboro pool or signal broader healthcare-sector instability.
Expected: BLS will release August and September metro-level unemployment and employment figures for Goldsboro in October, which should clarify whether the labor force contraction seen statewide is accelerating locally. A further drop in labor force size would sharpen the retention risk already visible in Triangle-area talent competition.
Potential inflection point: Kincellis Advanced Therapies' CDMO consolidation and new CSO hire may signal further contract-manufacturing consolidation across the region. Life sciences leaders weighing build-vs-outsource decisions should track whether CDMO capacity tightens or loosens as a result, since that directly affects the economics of outsourcing specialized manufacturing functions.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.